Richard S. Shames, Chief Medical Officer at Protagonist Therapeutics, Inc (PTGX), sold 2,017 shares at $19.00 ($38K) on 2017-10-05, disclosed to the SEC on 2017-10-10.
Scheduled sale ($38k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PTGX | SELL | 2017-12-27 | $145K | — | Filing → |
| PTGX | SELL | 2017-09-12 | $106K | — | Filing → |
| PTGX | SELL | 2017-08-30 | $26K | — | Filing → |